期刊文献+

盐酸普萘洛尔造模周期对豚鼠银屑病模型的影响 被引量:2

EFFECTS OF PROPRANOLOL HYDROCHLORIDE MODELING PERIOD ON GUINEA PIG MODELS OF PSORIASIS
下载PDF
导出
摘要 目的:研究5%盐酸普萘洛尔乳剂造模周期对豚鼠银屑病模型的影响。方法:5%盐酸普萘洛尔乳剂涂抹豚鼠耳部分别造模14d、21d和28d,测量豚鼠耳部表皮厚度,HE染色观察豚鼠耳部皮肤形态结构的变化。结果:随着5%盐酸普萘洛尔乳剂造模时间的延长,豚鼠耳部表皮厚度逐渐增加,耳部皮肤的病理变化逐渐加重。结论:5%盐酸普萘洛尔乳剂诱发豚鼠银屑病模型的严重程度为造模28d>造模21d>造模14d。 Objective: To study the effects of 5% propranolol hydrochloride emulsion molding period on guinea pig models of psoriasis. Methods: The guinea pig models of psoriasis were made by applying 5% propranolol hydrochloride emulsion to the ear of guinea pig respectively for 14 d, 21 d, and 28 d. The epidermal thickness of guinea pig's ear was measured; HE stain was used to observe the morphological changes of guinea pig's ear skin. Results: Along with modeling time extension, the epidermal thickness of guinea pig's ear increased gradually, the pathological changes of guinea pig's ear skin aggravated gradually. Conclusions: The severity that 5% propranolol hydrochloride emulsion induced guinea pig models of psoriasis is modeling time 28d〉21d〉14d.
作者 伍长娟 沈娟
出处 《承德医学院学报》 2015年第5期374-376,共3页 Journal of Chengde Medical University
关键词 银屑病 盐酸普萘洛尔 造模周期 动物实验 Psoriasis Propranolol hydrochloride Molding period Animal experiment
  • 相关文献

参考文献5

  • 1Lowes MA, Bowcock AM, Krueger JG. Pathogenesis and therapy of psoriasis[J]. Nature, 2007, 445(7130): 866-873.
  • 2Lubberts E, Koenders MI, van den Berg WB. The role of T-cell interleukin-17 in conducting destructive arthritis: lessons from animal models[J]. Arthritis Res Ther, 2005, 7(1): 29-37.
  • 3Yao N, Xia JX, Liu XM, et al. Topical application of a new monoclonal antibody against fibroblast growth factor 10 (FGF 10) mitigates propranolol-induced psoriasis-like lesions in guineapigs[J]. Eur Rev Med Pharmacol Sci, 2014, 18(7): 1085-1091.
  • 4曾灿丽,马桂芝,滕亮,戴秀勇,于富生,王长虹.骆驼蓬生物碱对银屑病模型小鼠的作用[J].中成药,2013,35(2):219-225. 被引量:16
  • 5孙林潮.银屑病动物模型研究进展[J].国外医学(皮肤性病学分册),1995,21(5):264-267. 被引量:18

二级参考文献20

  • 1陈蔚如,张海丽,张岩,冯英进.去氢骆驼蓬碱在小鼠的抗炎镇痛及止痒作用[J].天津医药,2004,32(11):681-683. 被引量:14
  • 2中华人民共和国卫生郎药典委员会.中华人民共和国卫生部药品标准(维吾尔药分册)[S],新疆:新疆科技卫生出版社,1999:80.
  • 3Van-Scott E J, Bonder R H. Intravaginal and intrarectal screen- ing of antimitotic drugs for topical effectiveners[ J]. Invest Der- matol, 1971, 56(2) : 132-139.
  • 4Spearman R I, Jarret A. Biological comparison of isomers and chemical forms of vitamin A [ J]. Br J Dermatol, 1974, 90 (5) : 553-560.
  • 5Jarret A. The physiology and pathophysiology of the skin [ M ]. London, New York: Academic Press, 1973 : 123.
  • 6Jahaniani F, Ebrahimi S A, Rahbar-Roshandel N, et al. Xan- thomicrol is "the main cytotoxic component of Dracocephalum kotschyii and a potential anti-cancer agent[J]. Phytochemistry, 2005, 66(13): 1581-1592.
  • 7Sobhanim A M, Ebrahimi S A, Mahmoudian M. An in vitro e- valuation of human DNA topoisomerase I inhibition by Peganum harmala L. seeds extract and its β-carboline alkaloids [ J ]. J Pharm Pharmaceut Sci, 2002, 5 (1) : 19-23.
  • 8边棣,李观海,张洪泉.去氢骆驼蓬碱对小鼠免疫功能的影响[J].新疆医科大学学报,1987,(04):299.
  • 9谭梦晖,金若敏,庞惠芳,周志兰,韩正宾,许伟国.复方银屑颗粒治疗小鼠银屑病模型的实验研究[J].上海中医药大学学报,2008,22(2):48-49. 被引量:7
  • 10王长虹,程雪梅,刘忠渊,孙殿甲,马正海,张富春,王峥涛.骆驼蓬种子提取物及其β咔保啉生物碱对DNA拓扑异构酶Ⅱ活性的抑制作用[J].中国临床药理学杂志,2008,24(5):422-425. 被引量:18

共引文献32

同被引文献30

  • 1朱凡,郑敏,鲍彰.银屑病患者皮损中血管内皮生长因子受体的表达与血管增生的关系[J].中华皮肤科杂志,2003,36(7):365-367. 被引量:33
  • 2孙林潮.银屑病动物模型研究进展[J].国外医学(皮肤性病学分册),1995,21(5):264-267. 被引量:18
  • 3LANGLEY RG, KRUEGER GG, GRIFFITHS CE, et al. Psoriasis: epidemiology, clinical features, and quality of life[J]. Ann Rheum Dis, 2005, 64 Suppl 2: 18-23.
  • 4ENAMANDRAM M, KIMBALL AB. Psoriasis epidemiology: the interplay of genes and the environment[J]. J Invest Dermatol, 2013, 33(2): 287-289.
  • 5OLIVEIRA MDE F, ROCHA BDE O, DUARTE GV. Psoriasis: classical and emerging comorbidities[J]. An Bras Dermatol, 2015, 90(1): 9-20.
  • 6WEINBERG JM, SAIN! R, TUTRONE WD. Biologic therapy for psoriasis--the first wave: infliximab, etanercept, efalizumab, and alefacept[J]. J Drugs Dermatol, 2002, 1 (3): 303-310.
  • 7胡雨来,吴江林.(e)m3,5一二甲氧基一4'一乙酰氧基二苯乙烯的制备方法:中国.CN201310225535[P].2013-08-28.
  • 8ZHAO L, CHEN X, CAI L, et ol. Randomized, double-blind, placebo-controlled, multiple-dose study of the safety, tolerability and pharmacokinetics of benvitimod, a candidate drug for the treatment of psoriasis[J]. J Clin Pharm Ther, 2014, 39(4): 418- 423.
  • 9KRANING KK. Research needs in 11 major areas in dermatology. I. Psoriasis[J]. J Invest Dermatol, 1979, 73(5 Pt 2): 402-413.
  • 10GAYLARDE PM, BROCK AP, SARKANY I. Psoriasiform changes in guinea-pig skin from propranolol[J]. Clin Exp Dermatol, 1978, 3(2): 157-160.

引证文献2

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部